The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 13, Issue 3, 1998, Pages 651-655

  Mulec, Henrik ^a   Blohmé, Göran ^b   Grände, Bo ^a   Björck, Staffan ^b  

^a Northern Alvsborg Hospital   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Diabetic nephropathy; Glomerular filtration rate; Glycaemic control; Insulin dependent diabetes mellitus; Renal failure

Indexed keywords

ALBUMIN; EDETIC ACID; GLUCOSE; HEMOGLOBIN A1C; PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; SWEDEN; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0031933328     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.3.651     Document Type: Article

References (34)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabelologia 1983; 25: 496-501
2. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985; 78: 785-794
3. U.S. Renal Data System, USRDS 1995 Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 1995
4. Schšn S, Swedish Registry for Active Treatment of Uraemia. Department of Nephrology, Skövde, Sweden 1995
5. Bojestig M, Arnqvist H, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15-18
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
7. The DCCT Research Group. Intensive therapy for diabetes. Kidney Int 1995; 47: 1703-1720
8. Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin dependent) diabetes. An update of the Steno studies. Diabetologia 1991; 34: 164-170
9. Dahl-Jörgensen K, Björo T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF. Long-term glycaemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992; 41: 920-923
10. Reichardt P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309
11. Microalbuminuria collaborative study group. Intensive therapy and progression to clinical albuminuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. Br Med J 1995; 311: 973-977
12. Wang PH, Lau J, Chalmers CT. Meta-analysis of effects of intensive blood-glucose control on late complications of type diabetes. Lancet 1993; 329: 977-986
13. Viberti G-C, Mogensen CE, Passa P, Bilous RW, Mangili R. St Vincent declaration, 1994. Guidelines for the prevention of diabetic renal failure. In: Mogensen CE, ed. The Kidney in Hypertension in Diabetes Mellitus. Kluwer Academic Publishers, 1994; 522-527
14. Brøchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-274
15. Hasslacher C, Stech W, Wahe P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin dependent) diabetes. Diabetologia 1985; 28: 6-11
16. Tamborlaine WV, Puklin JE, Bergman M et al. Long-term improvement of metabolic control with the Insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982; 5 [Suppl. 1]: 58-64
17. Viberti G-C, Bilous RW, Mackintosh D, Keen H. Monitoring glomerular function in diabetic nephropathy. Am J Med 1983; 74: 256-264
18. Viberti G-C, Bilous RW, Mackintosh D, Bending JJ, Keen H. Long term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 1983; 286: 598-602
19. Viberti G-C, Keen H, Dodde R, Bending JJ. Metabolic control and progression of diabetic nephropathy. Diabetologia 1987; 30: 481-422
20. Berglund J, Lins L-E, Lins P-E. Metabolic and blood pressure monitoring in diabetic renal failure. Acta Med Scand 1985; 218: 401-408
21. Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood-pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 1981; 20: 457-461
22. Nyberg G, Blohme G, Norden G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 1987; 30: 82-86
23. Parving H-H, Rossing P, Hommel E, Smidt UM. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 1995; 26: 99-107
24. Breyer JA, Bain RP, Evans JK et al. Predictors of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 1996; 50: 1651-1658
25. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249: F324-F337
26. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375-380
27. Striker G. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. J Am Soc Nephrol 1995; 5: 1537-1540
28. Mulec H, Johnsen SA, Wiklund O, Björck S. Cholesterol, a renal risk factor in diabetic nephropathy? Am J Kidney Dis 1993; 22: 196-201
29. Parving H-H, Rossing P. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 1994; 3: 292-300
30. Mogensen CE. Angiotensin converting enzyme inhibitors and diabetic nephropathy (editorial). Br Med J 1992; 304: 227-228
31. Lewis EJ, Hunsicker LG, Bain RP, Rohde R, for the collaborative study group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
32. Krolewski AS, Lafel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabets mellitus. N Engl J Med 1995; 332: 1251-1255
33. Warram JH, Mansson JAE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabets mellitus. N Engl J Med 1995; 332: 1305-1306
34. Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G. Long-term glycaemic control as a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Diabetes Care 1994; 17: 1390-1396